622 filings
Page 17 of 32
NT 10-Q
NBSE
NeuBase Therapeutics Inc
10 May 17
Notice of late quarterly filing
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
19 Apr 17
Submission of Matters to a Vote of Security Holders
12:00am
4
Backenroth Samuel
13 Apr 17
Ohr Pharmaceutical / Samuel Backenroth ownership change
12:00am
4
NBSE
NeuBase Therapeutics Inc
13 Apr 17
Ohr Pharmaceutical / Jason Scott Slakter ownership change
12:00am
4
Hirschman Orin
13 Apr 17
Ohr Pharmaceutical / ORIN HIRSCHMAN ownership change
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
10 Apr 17
Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants
12:00am
424B5
NBSE
NeuBase Therapeutics Inc
6 Apr 17
Prospectus supplement for primary offering
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
6 Apr 17
OHR PHARMACEUTICAL Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
12:00am
424B5
NBSE
NeuBase Therapeutics Inc
4 Apr 17
Prospectus supplement for primary offering
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
4 Apr 17
Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
12:00am
DEFA14A
NBSE
NeuBase Therapeutics Inc
3 Mar 17
Additional proxy soliciting materials
12:00am
DEF 14A
NBSE
NeuBase Therapeutics Inc
Definitive proxy
3 Mar 17
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
22 Feb 17
Other Events
12:00am
SC 13G/A
Hirschman Orin
15 Feb 17
Ohr Pharmaceutical Inc
12:00am
10-Q
2017 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 Feb 17
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
14 Feb 17
Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings
12:00am
NT 10-Q
NBSE
NeuBase Therapeutics Inc
9 Feb 17
Notice of late quarterly filing
12:00am
S-8
NBSE
NeuBase Therapeutics Inc
30 Dec 16
Registration of securities for employees
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
22 Dec 16
Ohr Pharmaceutical Reports Fiscal Year 2016 Financial and Business Results
12:00am
10-K
2016 FY
NBSE
NeuBase Therapeutics Inc
Annual report
22 Dec 16
12:00am